- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.08. | Exousia Bio, Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 04.08. | L A M Y: Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment | 416 | ACCESS Newswire | Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI) ORLANDO, FL / ACCESS Newswire / August 4, 2026 / Exousia Bio, Inc. f/k/a... ► Artikel lesen | |
| 22.07. | Exousia Pro, Inc.: NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform | 308 | GlobeNewswire (Europe) | Revised transaction expands NexTel's acquisition from JumpstartRx and NuevistraMed to Island 40 Group's broader growth platform, adding health services, pharmaceutical access, lab testing, institutional... ► Artikel lesen | |
| 16.06. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.06. | Exousia Pro, Inc.: NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University | 852 | GlobeNewswire (Europe) | Led by Scientific Advisory Board Members Dr. John Bitzer and Dr. Marvin Hausman, the Study Utilizes Advanced Mass Spectrometry to Identify the Precise Bioactive Healing Compounds Within Proprietary... ► Artikel lesen | |
| 02.06. | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 339 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 331 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 581 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 216 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 562 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 535 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 628 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 458 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 617 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOLV TECHNOLOGIES | 4,440 | 0,00 % | Evolv Technologies Holdings, Inc. - 10-Q, Quarterly Report | ||
| LIGHTWAVE LOGIC | 4,385 | -0,11 % | Lightwave Logic Q3 2026 slides: production delay to 2028 sinks stock | ||
| UNUSUAL MACHINES | 12,600 | 0,00 % | Unusual Machines Third Quarter 2026 Shareholder Letter | Revenue Increases 551% Year Over Year as Company Expands U.S. Manufacturing Capacity and Strengthens Position for 2027Conference call today at 4:30 p.m. ET ORLANDO, FL / ACCESS Newswire / November 5... ► Artikel lesen | |
| SERVE ROBOTICS | 3,105 | -0,16 % | Serve Robotics Q3 2026 Earnings Call Transcript | ||
| GPGI | 14,945 | 0,00 % | GPGI anticipates $630M-$660M Q4 net sales while lowering FY2026 EBITDA to $520M-$550M | ||
| ITURAN LOCATION AND CONTROL | 49,640 | 0,00 % | Dividendenbekanntmachungen (14.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,15 USD EUR AECOM US00766T1007 0,31 USD 0,2768 EUR AGREE REALTY CORPORATION US0084921008 0... ► Artikel lesen | |
| SARTORIUS AG VZ | 290,60 | -0,03 % | Drägerwerk führt, Sartorius hängt Carl Zeiss Meditec ab: Drei Aktien, drei sehr verschiedene Signale | ||
| 2G ENERGY | 46,600 | +4,06 % | 2G Energy: Kooperation mit 1Komma5° treibt die Aktie auf Erholungskurs | ||
| ASSALOY | 35,240 | -0,28 % | Dividendenbekanntmachungen (10.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD EUR AMBRA SA PLAMBRA00013 1,1 PLN EUR AMERICA MOVIL SAB DE CV MX01AM050019 0,27... ► Artikel lesen | |
| PVA TEPLA | 27,160 | +4,14 % | EQS-News: PVA TePla AG: PVA TePla mit wiederholt starkem Auftragseingang | EQS-News: PVA TePla AG
/ Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen
PVA TePla mit wiederholt starkem Auftragseingang
05.11.2026 / 07:00 CET/CEST
Für... ► Artikel lesen | |
| HUDSON TECHNOLOGIES | 4,440 | 0,00 % | HUDSON TECHNOLOGIES INC /NY - 10-Q, Quarterly Report | ||
| DRONESHIELD | 0,800 | +2,88 % | 500 Mio. US-Dollar, 14.500 Scanner, Millionen Entwickler: 4 australische Tech-Aktien greifen Amerika an | ||
| AIRJOULE TECHNOLOGIES | 2,385 | +0,21 % | AirJoule Technologies Corporation: AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business | Acquisition complements AirJoule Technologies' water technology with BitSink's well-established cooling solutions to address the critical infrastructure requirements of next-generation modular data... ► Artikel lesen | |
| WRAP TECHNOLOGIES | 1,220 | 0,00 % | WRAP Technologies Names Eric Bowen COO, Effective Nov. 16 | ||
| WABTEC | 271,00 | -0,37 % | $1000 Invested In Westinghouse Air Brake 5 Years Ago Would Be Worth This Much Today |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.